Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is gaining attention in the healthcare sector with a promising 26.17% potential upside based on analyst projections. This commercial-stage biopharmaceutical..
Definitive Healthcare Corp. (NASDAQ: DH) is a notable player in the healthcare information services sector, providing a comprehensive software-as-a-service (SaaS) healthcare commercial intelligence platform. Headquartered in..
Precigen, Inc. (NASDAQ: PGEN), a pioneering entity in the biotechnology sector, stands at the forefront of innovative gene and cell therapies. With a market capitalization of..
Cullinan Therapeutics, Inc. (CGEM), a clinical-stage biopharmaceutical company, is capturing the attention of investors with a remarkable potential upside of 116.39%. Headquartered in Cambridge, Massachusetts, Cullinan..
Oculis Holding AG (OCS), a pioneering name in the realm of biotechnology, specifically targets the healthcare sector with its innovative drug candidates aimed at ophthalmic, neuro-ophthalmic,..
Delcath Systems, Inc. (NASDAQ: DCTH), a standout player in the healthcare sector, specifically within the medical devices industry, is drawing significant attention from investors, thanks to..
Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company specializing in rare respiratory diseases, presents a compelling investment opportunity. With a market capitalization of approximately $989.8 million,..
Pharvaris N.V. (PHVS) is capturing the attention of investors with its promising potential upside of 84.17%. As a late-stage biopharmaceutical company headquartered in Zug, Switzerland, Pharvaris..
Valneva SE (NASDAQ: VALN) is a French biotechnology firm specializing in the development, manufacture, and commercialization of vaccines targeting infectious diseases with unmet medical needs. With..
Tilray Brands, Inc. (NASDAQ: TLRY), a prominent player in the healthcare sector and a leader in the drug manufacturers’ industry, has captured investor attention with its..
For investors with a keen eye on the biotechnology sector, Taysha Gene Therapies, Inc. (NASDAQ: TSHA) presents a compelling opportunity. With a remarkable potential upside of..
As investors scan the healthcare landscape for promising opportunities, Replimune Group, Inc. (NASDAQ: REPL) stands out with its innovative approach in the biotechnology sector. With a..
CeriBell, Inc. (CBLL), a pioneering healthcare company in the medical devices sector, is capturing attention with its innovative point-of-care EEG platform designed for acute care settings...
Castle Biosciences, Inc. (NASDAQ: CSTL), a key player in the healthcare sector’s diagnostics and research industry, presents a compelling case for investors looking to capitalize on..
Beta Bionics, Inc. (NASDAQ: BBNX) presents a compelling opportunity within the healthcare sector for investors seeking high-growth potential in the medical devices industry. With a market..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a promising player in the biotechnology sector, has been catching the eye of investors with its focus on addressing unmet medical..
Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a noteworthy player in the healthcare sector, specifically within the drug manufacturing industry focused on specialty and generic..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a key player in the biotechnology sector, is capturing investor attention with a notable potential upside of 28.33%. With its strong..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline and robust potential upside. Headquartered in..
CorMedix Inc. (NASDAQ: CRMD), a promising player in the biotechnology sector, is capturing investor attention with its significant upside potential of over 109%, according to analyst..
